About this FactMed analysis covering adverse side effect reports of ACTIT patients who developed HAEMODIALYSIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking ACTIT reported HAEMODIALYSIS to the FDA. A total of 67 ACTIT drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACTIT and HAEMODIALYSIS. In doing so, we compare ACTIT with other drugs that cause HAEMODIALYSIS, to help you evaluate whether or not ACTIT causes HAEMODIALYSIS. Likewise, this page shows the most highly-reported side effects of ACTIT, so you can see if HAEMODIALYSIS ranks among ACTIT's most well-known side effects.
Summary Statistics
Reports of ACTIT causing HAEMODIALYSIS: 2
Reports of any side effect of ACTIT : 67
Percentage of ACTIT patients where HAEMODIALYSIS is a reported side effect: 2.9851%

FDA reports of any drug causing HAEMODIALYSIS : 7350
Average percentage for all medicated patients where HAEMODIALYSIS is reported as a complication: 0.0461%

Physician opinion on ACTIT as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACTIT:
PYREXIA ( 5 patients )
INFUSION ( 4 patients )
DECREASED APPETITE ( 3 patients )
FLUID REPLACEMENT ( 2 patients )
ASTHMA ( 1 patients )
DEHYDRATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HAEMODIALYSIS:

ASPIRIN (678 patients)
FUROSEMIDE (514 patients)
METFORMIN HCL (492 patients)
PREDNISOLONE (437 patients)
CYCLOSPORINE (433 patients)
MYCOPHENOLATE MOFETIL (370 patients)
LASIX (349 patients)
PREDNISONE (345 patients)
ALLOPURINOL (320 patients)
OMEPRAZOLE (307 patients)
PROGRAF (279 patients)
AMLODIPINE (275 patients)
LISINOPRIL (263 patients)
DIGOXIN (260 patients)
SIMVASTATIN (258 patients)
METHYLPREDNISOLONE (241 patients)
ACETAMINOPHEN (239 patients)
VANCOMYCIN (235 patients)
LIPITOR (220 patients)
METHOTREXATE (213 patients)
ATENOLOL (209 patients)
INSULIN (197 patients)
NORVASC (197 patients)
ACYCLOVIR (196 patients)
METFORMIN HYDROCHLORIDE (196 patients)
RENAGEL (195 patients)
TACROLIMUS (181 patients)
NEXIUM (177 patients)
CYCLOPHOSPHAMIDE (176 patients)
NEORAL (172 patients)
IBUPROFEN (169 patients)
WARFARIN SODIUM (160 patients)
FOLIC ACID (159 patients)
RAPAMUNE (156 patients)
RAMIPRIL (155 patients)
HEPARIN (153 patients)
CELLCEPT (147 patients)
ZOCOR (144 patients)
HYDROCHLOROTHIAZIDE (143 patients)
CYTARABINE (143 patients)
METOPROLOL TARTRATE (141 patients)
PREDNISONE TAB (140 patients)
POTASSIUM CHLORIDE (137 patients)
LANSOPRAZOLE (136 patients)
VIOXX (134 patients)
EPOGEN (133 patients)
OMNISCAN (132 patients)
DEXAMETHASONE (130 patients)
SPIRONOLACTONE (129 patients)
ATORVASTATIN CALCIUM (128 patients)
CIPROFLOXACIN (126 patients)
DIOVAN (123 patients)
LEVOTHYROXINE SODIUM (123 patients)
LORAZEPAM (121 patients)
ENALAPRIL MALEATE (117 patients)
AZATHIOPRINE (113 patients)
HEPARIN SODIUM INJECTION (110 patients)
GABAPENTIN (110 patients)
FAMOTIDINE (109 patients)
ETOPOSIDE (109 patients)
AMLODIPINE BESYLATE (107 patients)
BACTRIM (107 patients)
CARVEDILOL (104 patients)
VELCADE (102 patients)
PLAVIX (102 patients)
LITHIUM CARBONATE (101 patients)
FENTANYL (99 patients)
PROPOFOL (99 patients)
PROTONIX (98 patients)
NITROGLYCERIN (98 patients)
METOPROLOL (98 patients)
RANITIDINE (96 patients)
SOLU-MEDROL (95 patients)
FLUCONAZOLE (95 patients)
COUMADIN (95 patients)
VALTREX (95 patients)
NIFEDIPINE (94 patients)
DIFLUCAN (93 patients)
CALCIUM CARBONATE (93 patients)
VOLTAREN (91 patients)
ARANESP (89 patients)
ALDACTONE (89 patients)
METFORMIN (87 patients)
CISPLATIN (86 patients)
MICARDIS (85 patients)
FABRAZYME (85 patients)
ALBUTEROL (83 patients)
LANTUS (82 patients)
THYMOGLOBULIN (81 patients)
METOCLOPRAMIDE (80 patients)
AMIODARONE HCL (79 patients)
ACETYLSALICYLIC ACID SRT (79 patients)
ZOMETA (77 patients)
COZAAR (77 patients)
SYNTHROID (77 patients)
PANTOPRAZOLE SODIUM (76 patients)
CLONIDINE (75 patients)
TOPROL-XL (75 patients)
VINCRISTINE (75 patients)
HEPARIN SODIUM (74 patients)
LEVAQUIN (73 patients)
NEURONTIN (72 patients)
VERAPAMIL (71 patients)
CLONAZEPAM (71 patients)
AREDIA (71 patients)
DIPRIVAN (71 patients)
LACTULOSE (70 patients)
CLARITHROMYCIN (69 patients)
MORPHINE (68 patients)
NYSTATIN (68 patients)
DOXAZOSIN MESYLATE (68 patients)
ZOFRAN (66 patients)
SIMULECT (66 patients)
BISOPROLOL FUMARATE (65 patients)
GLYBURIDE (65 patients)
PRILOSEC (64 patients)
DIANEAL (64 patients)
ALPRAZOLAM (63 patients)
COREG (62 patients)
METRONIDAZOLE (61 patients)
SANDIMMUNE (61 patients)
GLUCOPHAGE (61 patients)
DICLOFENAC SODIUM (61 patients)
FERROUS SULFATE TAB (61 patients)
NEUPOGEN (60 patients)
CALCITRIOL (60 patients)
MAGNESIUM OXIDE (60 patients)
HYDROCORTISONE (60 patients)
CRESTOR (59 patients)
GENTAMICIN (59 patients)
TRASYLOL (59 patients)
LOPRESSOR (59 patients)
CEFEPIME (59 patients)
ZANTAC (58 patients)
LOVENOX (56 patients)
VALSARTAN (56 patients)
CLOPIDOGREL (56 patients)
ATIVAN (56 patients)
LOXONIN (56 patients)
CARBAMAZEPINE (55 patients)
MIRTAZAPINE (55 patients)
HUMALOG (54 patients)
MIDAZOLAM HCL (54 patients)
ADALAT (53 patients)
GLEEVEC (53 patients)
HALOPERIDOL (53 patients)
ACTOS (53 patients)
AMARYL (52 patients)
TRAMADOL HCL (52 patients)
VICODIN (52 patients)
SODIUM BICARBONATE (51 patients)
ATORVASTATIN (51 patients)
CEFTRIAXONE (51 patients)
ZOLOFT (51 patients)
DIAZEPAM (51 patients)
ERYTHROMYCIN (51 patients)
OXYCODONE HCL (50 patients)
DILTIAZEM (50 patients)
LAMOTRIGINE (50 patients)
TORSEMIDE (50 patients)
LEVOFLOXACIN (49 patients)
THALIDOMIDE (49 patients)
SIROLIMUS (49 patients)
PROCRIT (49 patients)
CARBOPLATIN (48 patients)
PEPCID (48 patients)
MUCOSTA (47 patients)
IRON (47 patients)
PHENYTOIN (47 patients)
SULFAMETHOXAZOLE + TRIMETHOPRIM (47 patients)
FLUOROURACIL (47 patients)
CORDARONE (46 patients)
NAPROXEN (46 patients)
GLIPIZIDE (46 patients)
ROCEPHIN (46 patients)
PURSENNID (46 patients)
TEGRETOL (45 patients)
PANTOPRAZOLE (45 patients)
DOXORUBICIN HCL (45 patients)
DECADRON (45 patients)
ONDANSETRON (44 patients)
PRIMAXIN (44 patients)
MAGNEVIST (44 patients)
DEXAMETHASONE TAB (44 patients)
SELBEX (44 patients)
MEROPENEM (44 patients)
LOSARTAN POTASSIUM (44 patients)
CITALOPRAM HYDROBROMIDE (43 patients)
ISOSORBIDE MONONITRATE (43 patients)
CAPTOPRIL (43 patients)
FLUDARABINE PHOSPHATE (43 patients)
GANCICLOVIR (43 patients)
FENOFIBRATE (43 patients)
AMBIEN (43 patients)
XANAX (43 patients)
VALPROATE SODIUM (43 patients)
THEOPHYLLINE (43 patients)
PHOSLO (43 patients)
GASTER (43 patients)
SEROQUEL (42 patients)
REMICADE (42 patients)
BLOPRESS (42 patients)
. (42 patients)
OLANZAPINE (42 patients)
IRBESARTAN (42 patients)
THALOMID (42 patients)
METOPROLOL SUCCINATE (41 patients)
TRACLEER (41 patients)
CANDESARTAN CILEXETIL (41 patients)
PERCOCET (41 patients)
Most common side effects for patients taking ACTIT:
BLOOD POTASSIUM DECREASED (12 patients)
DIZZINESS POSTURAL (12 patients)
MULTIPLE SCLEROSIS RELAPSE (12 patients)
PALPITATIONS (12 patients)
LIVER DISORDER (7 patients)
NAUSEA (7 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (6 patients)
PYREXIA (6 patients)
ALANINE AMINOTRANSFERASE INCREASED (5 patients)
DYSPNOEA (5 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (5 patients)
HYPERTHERMIA (5 patients)
BLOOD PRESSURE DECREASED (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
HEPATIC FUNCTION ABNORMAL (4 patients)
ILEUS (4 patients)
PNEUMONIA (4 patients)
PNEUMONIA ASPIRATION (4 patients)
STEVENS-JOHNSON SYNDROME (4 patients)
WHITE BLOOD CELL COUNT INCREASED (4 patients)
ANOREXIA NERVOSA (3 patients)
DECREASED APPETITE (3 patients)
DEPRESSION (3 patients)
DIARRHOEA (3 patients)
DRUG WITHDRAWAL SYNDROME (3 patients)
DYSPHORIA (3 patients)
GASTROINTESTINAL ULCER (3 patients)
HAEMATOCRIT DECREASED (3 patients)
MALAISE (3 patients)
PARKINSONISM (3 patients)
RENAL FAILURE (3 patients)
SHOCK HAEMORRHAGIC (3 patients)
SOMNOLENCE (3 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (3 patients)
VOMITING (3 patients)
ANORECTAL OPERATION (2 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (2 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (2 patients)
BLOOD UREA INCREASED (2 patients)
BRONCHIAL HAEMORRHAGE (2 patients)
CARDIAC FAILURE (2 patients)
COLD SWEAT (2 patients)
COUGH (2 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (2 patients)
DRUG ERUPTION (2 patients)
DYSKINESIA (2 patients)
DYSURIA (2 patients)
FIBRINOLYSIS INCREASED (2 patients)
GENERALISED ERYTHEMA (2 patients)
HAEMODIALYSIS (2 patients)
HAEMORRHAGE SUBCUTANEOUS (2 patients)
HEPARIN-INDUCED THROMBOCYTOPENIA (2 patients)
HEPATITIS ACUTE (2 patients)
HEPATITIS FULMINANT (2 patients)
MELAENA (2 patients)
PAIN (2 patients)
PLATELET COUNT DECREASED (2 patients)
PLATELET COUNT INCREASED (2 patients)
PNEUMONIA BACTERIAL (2 patients)
PRODUCTIVE COUGH (2 patients)
PROTEIN TOTAL DECREASED (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE ACUTE (2 patients)
RESPIRATORY ARREST (2 patients)
THROMBOCYTOPENIA (2 patients)
URINARY TRACT INFECTION (2 patients)
WHEEZING (2 patients)
WHITE BLOOD CELL COUNT DECREASED (2 patients)
ABNORMAL BEHAVIOUR (1 patients)
ANOREXIA (1 patients)
BACK PAIN (1 patients)
BLOOD GLUCOSE INCREASED (1 patients)
BLOOD PRESSURE INCREASED (1 patients)
BLOOD URINE PRESENT (1 patients)
BRADYCARDIA (1 patients)
C-REACTIVE PROTEIN INCREASED (1 patients)
CACHEXIA (1 patients)
CAESAREAN SECTION (1 patients)
CHILLS (1 patients)
CHOLANGITIS SCLEROSING (1 patients)
COAGULATION TEST ABNORMAL (1 patients)
COAGULOPATHY (1 patients)
COMA (1 patients)
CONJUNCTIVAL HYPERAEMIA (1 patients)
CONSTIPATION (1 patients)
CONVULSION (1 patients)
DEATH (1 patients)
DIZZINESS (1 patients)
DRUG EXPOSURE DURING PREGNANCY (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG INTERACTION (1 patients)
FALL (1 patients)
FEELING ABNORMAL (1 patients)
FOETAL GROWTH RETARDATION (1 patients)
FUNGAL TEST POSITIVE (1 patients)
GASTROINTESTINAL DISORDER (1 patients)
GASTROINTESTINAL HAEMORRHAGE (1 patients)
HEADACHE (1 patients)
HEPATIC NEOPLASM MALIGNANT (1 patients)
HYPERCALCAEMIA (1 patients)
HYPERKALAEMIA (1 patients)
HYPOMANIA (1 patients)
INJURY ASPHYXIATION (1 patients)
INTERSTITIAL LUNG DISEASE (1 patients)
IRRITABILITY (1 patients)
LIVER FUNCTION TEST ABNORMAL (1 patients)
LYMPHADENOPATHY (1 patients)
LYMPHOCYTE STIMULATION TEST POSITIVE (1 patients)
MALNUTRITION (1 patients)
MUSCLE RIGIDITY (1 patients)
MYDRIASIS (1 patients)
OCULOMUCOCUTANEOUS SYNDROME (1 patients)
ORGANISING PNEUMONIA (1 patients)
PLEURAL EFFUSION (1 patients)
POST PROCEDURAL COMPLICATION (1 patients)
PRE-ECLAMPSIA (1 patients)
PROCTALGIA (1 patients)
PULMONARY TUBERCULOSIS (1 patients)
RASH GENERALISED (1 patients)
RED BLOOD CELL ANISOCYTES PRESENT (1 patients)
RENAL CELL CARCINOMA (1 patients)
RESPIRATORY DISORDER (1 patients)
SEPSIS (1 patients)
SPEECH DISORDER (1 patients)
STUPOR (1 patients)
SUDDEN DEATH (1 patients)
TACHYCARDIA (1 patients)
WHITE BLOOD CELLS URINE POSITIVE (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ACTIT


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HAEMODIALYSIS and ACTIT, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACTIT, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACTIT. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACTIT experts. If you are a healthcare provider experienced in prescribing ACTIT, please register here.
giCould not connect: